Angela Krackhardt is Professor of Translational Immunotherapy and senior physician at the department of Hematology and Oncology at the III. Medical Department, TU München, Germany. She studied Medicine in Berlin and accomplished her clinical training in Internal Medicine, Hematology and Oncology, in Berlin and Munich. She did a Postdoc at the Dana Farber Cancer Institute in Boston, USA, followed by an appointment as Instructor. In 2005, she started her own Research Group at the Institute of Molecular Immunology, Helmholtz Zentrum München. In 2010, she was appointed as Professor at the TU München and is additionally appointed as senior physician at the Klinikum rechts der Isar. Her scientific focus is the identification of target antigens, especially neoantigens most suitable for T-cell based immunotherapies, the genetic manipulation of T-effector cells by tumor-reactive T-cell receptors, the establishment of xenogenic mouse models and development of in vivo imaging of tumor-reactive T cells. Her clinical focus is the implementation and translation of novel immunotherapeutic approaches including cellular therapies. She is additionally Director of the apheresis unit and heads specialty clinics for patients with malignant melanoma and multiple myeloma.